logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
05/08/2026
Novo Nordisk: Expects to launch the oral formulation of Wegovy in Germany in September.
Latest
1 m ago
Meta's pre-market shares rose over 2%.
1 m ago
Kaiwang Technology (301182.SZ) plans to acquire 51% equity in Dongguan Qinding and Dongguan Xingding for 286 million yuan.
2 m ago
Bohua Bio (06955.HK): Injection solution of Abicipar submitted for marketing authorization in Brazil
2 m ago
Novo Nordisk CEO: We are increasingly surprised by the high market demand for the oral version of Wegovy compared to the injectable version.
3 m ago
Woyang Automation: Abnormal fluctuations in stock trading; there are no undisclosed significant matters that should be disclosed.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.